P/F Bakkafrost logo

BAKKAo - P/F Bakkafrost News Story

NOK716.6 55.0  8.3%

Last Trade - 06/05/21

Sector
Consumer Defensives
Size
Large Cap
Market Cap £3.59bn
Enterprise Value £3.84bn
Revenue £540.2m
Position in Universe 163rd / 1831

NORDIC STOCKS - Factors to watch on Nov 3

Tue 3rd November, 2015 6:24am
The following stocks may be affected by newspaper reports and 
other factors on Tuesday: 
     
    COLOPLAST  COLOb.CO  
    The Danish company that makes healthcare products ranging 
from ostomy and urine bags to wound dressings is expected to 
report a fourth quarter pretax loss of 1.9 billion Danish crowns 
($280.55 million) on Tuesday after setting aside 3 billion 
crowns for a U.S. lawsuit. 
    For more on the company, click on  COLOb.CO  
     
    BAKKAFROST  BAKKA.OL   
    The Norwegian fish farmer posted third-quarter operational 
EBIT below expectations on Tuesday and said it expected harvest 
volumes next year to decline by four percent compared to this 
year. 
    For more on the company, click on  BAKKA.OL  
     
    ** For a summary of upcoming results and forecasts, double 
click on  NORD/EQTY  
    ** For the western European company diary covering earnings, 
shareholder meetings, news conferences and analysts' meetings, 
click on  WEU/EQUITY  or type in the code and hit the f9 button. 
    ** Double click on  0#.INDEX.ST  for Swedish indices, 
 0#.INDEX.CO  for Danish indices,  0#.INDEX.HE  for Finnish 
indices and  0#.INDEX.OL  for Norwegian indices 
    ** For real-time moves on Nordic blue-chip indices double 
click on  .OMXS30 ,  .OMXH25 ,  .OMXC20  and  .OBX  
    ** For constituent stock moves highlight the above codes in 
the command box and press the f3 button on your keyboard 
    ** For Nordic top news items, double click on  TOP/NORD  
    ** For the latest news on Nordic stock price moves double 
click on  HOT-NORD-RTRS  
    (Reporting by Copenhagen, Oslo, Helsinki and Stockholm 
newsrooms) 
 
 
Keywords: NORDICS MARKETS/FACTORS
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.